Literature DB >> 33596656

Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA.

Chunhui Li1, Junhui Zhou2, Yidi Wu3, Yanliang Dong2, Lili Du3, Tongren Yang1, Yongheng Wang4, Shuai Guo1, Mengjie Zhang1, Abid Hussain1,5,6, Haihua Xiao4, Yuhua Weng1, Yong Huang7, Xiaoxia Wang3, Zicai Liang3,8, Huiqing Cao3, Yongxiang Zhao7, Xing-Jie Liang5, Anjie Dong2,8, Yuanyu Huang1.   

Abstract

Efficient endosomal escape is the most essential but challenging issue for siRNA drug development. Herein, a series of quaternary ammonium-based amphiphilic triblock polymers harnessing an elaborately tailored pH-sensitive hydrophobic core were synthesized and screened. Upon incubating in an endosomal pH environment (pH 6.5-6.8), mPEG45-P(DPA50-co-DMAEMA56)-PT53 (PDDT, the optimized polymer) nanomicelles (PDDT-Ms) and PDDT-Ms/siRNA polyplexes rapidly disassembled, leading to promoted cytosolic release of internalized siRNA and enhanced silencing activity evident from comprehensive analysis of the colocalization and gene silencing using a lysosomotropic agent (chloroquine) and an endosomal trafficking inhibitor (bafilomycin A1). In addition, PDDT-Ms/siPLK1 dramatically repressed tumor growth in both HepG2-xenograft and highly malignant patient-derived xenograft models. PDDT-Ms-armed siPD-L1 efficiently blocked the interaction of PD-L1 and PD-1 and restored immunological surveillance in CT-26-xenograft murine model. PDDT-Ms/siRNA exhibited ideal safety profiles in these assays. This study provides guidelines for rational design and optimization of block polymers for efficient endosomal escape of internalized siRNA and cancer therapy.

Entities:  

Keywords:  block polymer; cancer immunotherapy; endosomal escape; pH-response; siRNA delivery

Mesh:

Substances:

Year:  2021        PMID: 33596656     DOI: 10.1021/acs.nanolett.0c04468

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  11 in total

1.  Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation.

Authors:  Dipika Nandi; Manisha Shivrayan; Jingjing Gao; Jithu Krishna; Ritam Das; Bin Liu; S Thayumanavan; Ashish Kulkarni
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-20       Impact factor: 10.383

Review 2.  mRNA-based modalities for infectious disease management.

Authors:  Mengjie Zhang; Abid Hussain; Haiyin Yang; Jinchao Zhang; Xing-Jie Liang; Yuanyu Huang
Journal:  Nano Res       Date:  2022-07-06       Impact factor: 10.269

3.  Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma.

Authors:  Le-Le Zhou; Qun Guan; Wei Zhou; Jing-Lan Kan; Yu-Bin Dong
Journal:  Chem Sci       Date:  2022-06-15       Impact factor: 9.969

4.  Anti-MicroRNA-21 Oligonucleotide Loaded Spermine-Modified Acetalated Dextran Nanoparticles for B1 Receptor-Targeted Gene Therapy and Antiangiogenesis Therapy.

Authors:  Tao Zheng; Wentao Wang; Mohsen Mohammadniaei; Jon Ashley; Ming Zhang; Ninglin Zhou; Jian Shen; Yi Sun
Journal:  Adv Sci (Weinh)       Date:  2021-12-22       Impact factor: 16.806

5.  Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B.

Authors:  Yuanyu Huang; Shuquan Zheng; Zhaoxu Guo; Xavier de Mollerat du Jeu; Xing-Jie Liang; Zhiwei Yang; Hong-Yan Zhang; Shan Gao; Zicai Liang
Journal:  Signal Transduct Target Ther       Date:  2022-02-11

6.  Conscription of Immune Cells by Light-Activatable Silencing NK-Derived Exosome (LASNEO) for Synergetic Tumor Eradication.

Authors:  Mengjie Zhang; Wanxuan Shao; Tongren Yang; Houli Liu; Shuai Guo; Deyao Zhao; Yuhua Weng; Xing-Jie Liang; Yuanyu Huang
Journal:  Adv Sci (Weinh)       Date:  2022-06-04       Impact factor: 17.521

Review 7.  Polymeric Carriers for Delivery of RNA Cancer Therapeutics.

Authors:  Sofía Mirón-Barroso; Joana S Correia; Adam E Frampton; Mark P Lythgoe; James Clark; Laura Tookman; Silvia Ottaviani; Leandro Castellano; Alexandra E Porter; Theoni K Georgiou; Jonathan Krell
Journal:  Noncoding RNA       Date:  2022-08-02

Review 8.  Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.

Authors:  Jinxing Huang; Kai Xiao
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

9.  Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy.

Authors:  Shiou-Fen Hung; Yu-Han Wen; Lu-Yi Yu; Hsin-Cheng Chiu; Yi-Ting Chiang; Chun-Liang Lo
Journal:  Polymers (Basel)       Date:  2021-05-31       Impact factor: 4.329

Review 10.  mRNA vaccines for COVID-19 and diverse diseases.

Authors:  Abid Hussain; Haiyin Yang; Mengjie Zhang; Qing Liu; Ghallab Alotaibi; Muhammad Irfan; Huining He; Jin Chang; Xing-Jie Liang; Yuhua Weng; Yuanyu Huang
Journal:  J Control Release       Date:  2022-03-21       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.